Dr_Jonas_Halvorsen
I test before I trust, and I post the numbers either way.
28kreputation
90answers
12accepted
19questions
0·3·7badges g·s·b
68tags
156What does the mechanism of semaglutide predict that STEP 5 did not test?accepted · answered 21 Sept 2024 · glp1-mechanism, clinical-trials, gip-receptor97What does SURPASS-3 report at the 5 mg dose level?accepted · answered 10 Jun 2024 · clinical-trials, dosing-math, titration90What did the placebo arm of SUSTAIN-6 report for reflux?answered 1 Jan 2025 · clinical-trials, gi-side-effects78My survodutide vial sat at 25 °C for twenty-one days — is testing worth it before use?answered 9 May 2025 · cold-chain, peptide-stability, batch-testing77What does 98.8% purity on a C18 column actually tell me about a semaglutide vial?answered 23 Jun 2024 · hplc, purity, coa71What does SURMOUNT-4 tell me about constipation at the 5 mg dose?accepted · answered 5 Mar 2025 · clinical-trials, constipation, titration69What does SURMOUNT-5 tell me about nausea at the 10 mg dose?accepted · answered 28 Apr 2026 · clinical-trials, nausea, titration63Would you accept 96.4% on a GLP-1 receptor agonist from QST without a content assay?answered 30 Aug 2024 · purity, content-assay, vendor-vetting62Would you accept 97.9% on ecnoglutide from WWB without a content assay?answered 28 Dec 2024 · purity, content-assay, vendor-vetting61What did the placebo arm of SOUL report for early satiety?accepted · answered 4 Sept 2024 · clinical-trials, gi-side-effects59How long does orforglipron stay within specification at 37 °C once reconstituted?answered 6 Mar 2025 · peptide-stability, storage, shelf-life59What did the placebo arm of SURMOUNT-5 report for injection-site erythema?answered 6 Aug 2024 · clinical-trials, injection-site-reaction57What does SURMOUNT-4 tell me about constipation at the 5 mg dose?answered 17 Mar 2025 · clinical-trials, constipation, titration51How do I convert the SURMOUNT-5 hazard ratio into an absolute risk reduction?answered 5 Nov 2024 · cardiovascular, clinical-trials, dosing-math49What does TRIUMPH-1 report at the 8 mg dose level?answered 26 Nov 2024 · clinical-trials, dosing-math, titration47What exactly did the FLOW renal composite measure?answered 29 Mar 2026 · renal-outcomes, kidney-function, clinical-trials46Is a titration interval of ten weeks better supported than four weeks for a GLP-1 receptor agonist?accepted · answered 3 May 2025 · titration, dose-escalation, clinical-trials46Is there any published stability data for ecnoglutide at 37 °C?accepted · answered 25 Oct 2025 · peptide-stability, storage, clinical-trials45Does albuminuria regression translate into hard renal endpoints?answered 11 Jun 2025 · renal-outcomes, kidney-function, clinical-trials37What does FLOW tell me about dizziness at the 1 mg dose?answered 21 Jun 2024 · clinical-trials, titration36Does the SURMOUNT-2 population resemble anyone asking about tirzepatide here?answered 25 Jan 2026 · clinical-trials, harm-reduction, semaglutide35Does the STEP 3 population resemble anyone asking about a GLP-1 receptor agonist here?answered 16 Jul 2024 · clinical-trials, harm-reduction, semaglutide32Is a titration interval of ten weeks better supported than four weeks for a GLP-1 receptor agonist?answered 22 Apr 2025 · titration, dose-escalation, clinical-trials32Is SSA worth the price difference against Qingdao Saber Technology on measured results?answered 5 Nov 2024 · vendor-comparison, cost-analysis, batch-testing32What does SURMOUNT-5 tell me about fatigue at the 10 mg dose?answered 26 Sept 2024 · clinical-trials, fatigue, titration32Why did my solution foam when I added the diluent, and does it matter?answered 3 Feb 2025 · reconstitution, vial-inspection, peptide-stability31How do I model twelve months of oral semaglutide across supply routes?answered 7 Dec 2024 · cost-analysis, insurance, compounding31Is a 99.4% result from Janoshik comparable to 97.1% from PeptideMeter?answered 18 Mar 2026 · purity, batch-testing, reference-standard30How many freeze-thaw cycles will orforglipron at 20 mg/mL tolerate?answered 28 Mar 2025 · freeze-thaw, peptide-stability, storage29What did the placebo arm of SURMOUNT-4 report for early satiety?accepted · answered 28 Jun 2025 · clinical-trials, gi-side-effects28How do I reconcile 95.2% from Janoshik with 99.4% from the supplier?answered 3 Jul 2025 · purity, batch-testing, coa27How comparable are cagrilintide and semaglutide on the evidence available?answered 28 Oct 2025 · clinical-trials, semaglutide, tirzepatide27How is albuminuria regression measured across a trial?answered 15 Aug 2025 · renal-outcomes, kidney-function, clinical-trials27Is 60 mg in 2.5 mL of bacteriostatic water a sensible presentation for oral semaglutide?answered 10 Feb 2026 · diluent-volume, reconstitution, dosing-math26What does 99.1% purity on a C8 column actually tell me about an oral semaglutide vial?answered 4 Jun 2024 · hplc, purity, coa25Is 1 mg weekly a defensible maintenance dose for a GLP-1 receptor agonist?answered 22 Jan 2026 · maintenance-dose, clinical-trials, dosing-math25Is survodutide at 2 mg/mL stable enough for ten weeks of multi-withdrawal use?answered 26 Jul 2026 · peptide-stability, bacteriostatic-water, shelf-life25Would you re-test mazdutide after six weeks at 2–8 °C, or accept the original certificate?answered 6 Oct 2025 · batch-testing, peptide-stability, coa24What did the placebo arm of STEP 3 report for hair thinning?answered 25 Aug 2024 · clinical-trials, hair-loss24What does SELECT report at the 2 mg dose level?answered 21 Jan 2026 · clinical-trials, dosing-math, titration23What did the placebo arm of FLOW report for early satiety?answered 14 Jul 2026 · clinical-trials, gi-side-effects22How do I reconcile 95.2% from Medutest with 97.1% from the supplier?answered 20 Jun 2026 · purity, batch-testing, coa22What does TRIUMPH-1 tell me about early satiety at the 8 mg dose?answered 28 Sept 2024 · clinical-trials, gi-side-effects, titration21What did the placebo arm of TRIUMPH-1 report for fatigue?answered 26 Dec 2025 · clinical-trials, fatigue21What did the placebo arm of TRIUMPH-3 report for dizziness?answered 19 Nov 2025 · clinical-trials, harm-reduction21What does the mechanism of tirzepatide predict that SURPASS-3 did not test?answered 5 Feb 2025 · glp1-mechanism, clinical-trials, gip-receptor21Would you accept 95.2% on semaglutide from SGN without a content assay?answered 29 Mar 2026 · purity, content-assay, vendor-vetting19Is 98.4% a realistic purity ceiling for a GLP-1 receptor agonist given its chain length?answered 23 Nov 2025 · purity, hplc, peptide-mapping18Is 15 mg in 2 mL of phosphate-buffered diluent a sensible presentation for orforglipron?answered 7 Apr 2026 · diluent-volume, reconstitution, dosing-math18Why does STEP 1 report -14.9% when other papers quote about -17% for the same 2.4 mg dose?answered 8 Aug 2024 · semaglutide, clinical-trials, dosing-math17What did TRIUMPH-3 do with participants who could not tolerate a step?answered 27 Jul 2026 · titration, clinical-trials, gi-side-effects16Does nausea at week ten of retatrutide usually resolve without a dose change?answered 27 Dec 2025 · nausea, titration, retatrutide16What does SURPASS-3 tell me about hair thinning at the 5 mg dose?answered 20 May 2026 · clinical-trials, hair-loss, titration15What did the placebo arm of PIONEER-1 report for injection-site erythema?answered 17 Jan 2025 · clinical-trials, injection-site-reaction14How comparable are orforglipron and tirzepatide on the evidence available?answered 5 Mar 2026 · clinical-trials, semaglutide, tirzepatide14What does 98.8% purity on a C4 column actually tell me about a retatrutide vial?answered 20 Jun 2024 · hplc, purity, coa13What does an endotoxin test add for a GLP-1 receptor agonist that a purity figure does not?answered 16 Jul 2026 · content-assay, purity, coa13What does PIONEER-1 tell me about constipation at the 7 mg dose?answered 29 Jun 2026 · clinical-trials, constipation, titration12Is there any published stability data for cagrilintide at 37 °C?answered 13 May 2024 · peptide-stability, storage, clinical-trials12What AHI reduction did SURMOUNT-OSA report, and from which baseline?answered 28 Oct 2025 · sleep-apnea, clinical-trials, cardiovascular11How do I convert the PIONEER-4 hazard ratio into an absolute risk reduction?accepted · answered 26 May 2026 · cardiovascular, clinical-trials, dosing-math11Is 1.6 g/kg protein evidence-based during an energy deficit?answered 31 Dec 2024 · protein-intake, nutrition, clinical-trials11What does REDEFINE-1 actually establish about cagrilintide?answered 19 Aug 2024 · clinical-trials, semaglutide, cardiovascular11What does STEP 1 report at the 1 mg dose level?answered 20 Jul 2026 · clinical-trials, dosing-math, titration10What does SURPASS-3 tell me about injection-site erythema at the 10 mg dose?answered 26 Oct 2025 · clinical-trials, injection-site-reaction, titration10What does SUSTAIN-6 report at the 2.4 mg dose level?answered 24 May 2025 · clinical-trials, dosing-math, titration9Is there any published stability data for retatrutide at minus 20 °C?answered 3 Jan 2025 · peptide-stability, storage, clinical-trials9Is there any published stability data for survodutide at 30 °C?answered 26 Mar 2025 · peptide-stability, storage, clinical-trials8How do I compare HJ and QYB on lead time to the United Kingdom?answered 29 Jun 2026 · vendor-comparison, international-shipping, cold-chain8How long does a Suzhou to the United States lane usually take with tracking?answered 23 Feb 2025 · international-shipping, customs, cold-chain8Is an on-chain payment sensible for an order shipping to Spain?answered 1 Mar 2026 · payment-privacy, group-buy, international-shipping8What did the placebo arm of ATTAIN-1 report for constipation?answered 14 Jun 2025 · clinical-trials, constipation7What does SELECT tell me about dizziness at the 2 mg dose?answered 5 Aug 2024 · clinical-trials, titration7Would you accept 98.2% on mazdutide from TFC without a content assay?answered 23 Sept 2025 · purity, content-assay, vendor-vetting6How do I check that two QYB lots of semaglutide agree on content assay?answered 27 Feb 2026 · batch-testing, content-assay, vendor-vetting6What did the placebo arm of REDEFINE-1 report for hair thinning?accepted · answered 10 Jul 2026 · clinical-trials, hair-loss6What did the placebo arm of SELECT report for dizziness?accepted · answered 6 Jun 2026 · clinical-trials, harm-reduction6What does TRIUMPH-1 report at the 8 mg dose level?accepted · answered 7 Dec 2024 · clinical-trials, dosing-math, titration6Would you re-test a GLP-1 receptor agonist after six weeks at minus 20 °C, or accept the original certificate?answered 30 May 2026 · batch-testing, peptide-stability, coa5Is 1.6 g/kg protein evidence-based during an energy deficit?answered 8 Apr 2025 · protein-intake, nutrition, clinical-trials4Does a phase-change pack hold a mazdutide shipment for five days in transit?answered 19 Jun 2024 · cold-chain, international-shipping, storage4Why did my ApoB move after sixteen weeks on oral semaglutide?answered 26 Apr 2025 · bloodwork, kidney-function, lipids3Does holding at 0.25 mg for two weeks before escalating reduce nausea?answered 7 Jul 2026 · titration, nausea, dose-escalation2What did the placebo arm of PIONEER-1 report for dizziness?answered 10 Nov 2025 · clinical-trials, harm-reduction2What does SOUL tell me about dizziness at the 7 mg dose?answered 28 Jun 2025 · clinical-trials, titration-1What did the placebo arm of SURMOUNT-OSA report for reflux?answered 25 Jan 2026 · clinical-trials, gi-side-effects-2What does SURMOUNT-4 report at the 5 mg dose level?answered 21 Apr 2025 · clinical-trials, dosing-math, titration-3Is 6.67 mg/mL a sensible working concentration for liraglutide, or should I go lower?answered 7 Oct 2025 · diluent-volume, reconstitution, dosing-math-3What does TRIUMPH-1 tell me about early satiety at the 8 mg dose?answered 17 Sept 2024 · clinical-trials, gi-side-effects, titration-3What should a visual inspection of an FGP vial cover before reconstitution?answered 28 Feb 2026 · vial-inspection, harm-reduction, sterility